Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: A new way to improve its therapeutic index

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2345-2351

  Gaboriau, François ^a   Chéron, Monique ^a   Petit, Caroline ^a   Bolard, Jacques ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; LACTATE DEHYDROGENASE;

ANTIFUNGAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANDIDA ALBICANS; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEATING; HEMOLYSIS; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; POLYMERIZATION; POTASSIUM TRANSPORT; PRIORITY JOURNAL;

EID: 0342276112     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2345     Document Type: Article

References (36)

1. Adler-Moore, J. P., and R. T. Proffitt. 1993. Development, characterization, efficacy and mode of action of Ambisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3:429-451.
2. Balakrishnan, A. R., and K. R. K. Easwaran. 1993. CD and NMR studies on the aggregation of amphotericin B in solution. Biochim. Biophys. Acta 1148: 269-277.
3. Barwicz, J., S. Christian, and I. Gruda. 1992. Effects of the aggregation state of amphotericin B on its toxicity to mice. Antimicrob. Agents Chemother. 36:2310-2315.
4. Barwicz, J., W. I. Gruszecki, and I. Gruda. 1993. Spontaneous organization of amphotericin B in aqueous medium. J. Colloid Interface Sci. 158:71-76.
5. Bennet, J. E., G. J. Hill, W. T. Butler, and W. E. Chester. 1963. Correlation of particle size of intravenous amphotericin B with toxic and chemotherapeutic effect. Antimicrob. Agents Chemother. 3:745-752.
6. Bergmeyer, H. U., E. Bernt, and B. Hess. 1963. Lactic dehydrogenase, p. 736-741. In H. U. Bergmeyer (ed.), Methods of enzymatic analysis. Verlag Chemie, Weinheim, Germany.
7. Bolard J., M. Seigneuret, and G. Boudet. 1980. Interaction between phospholipid bilayer membranes and the polyene antibiotic amphotericin B. Biochim. Biophys. Acta 599:280-293.
8. Bolard, J. 1986. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim. Biophys. Acta 864:257-304.
9. Bolard, J., P. Legrand, F. Heitz, and B. Cybulska. 1991. One-sided action of amphotericin B on cholesterol-containing membranes is determined by its self-association in the medium. Biochemistry 30:5707-5715.
10. Bolard, J., V. Joly, and P. Yéni. 1993. Mechanism of action of amphotericin B at the cellular level. Its modulation by delivery systems. J. Liposome Res. 3:409-429.
11. Brajtburg, J., S. Elberg, J. Medoff, G. Kobayashi, D. Schlessinger, and G. Medoff. 1984. Stimulatory, permeabilizing, and toxic effects of AmB on L cells. Antimicrob. Agents Chemother. 26:892-897.
12. Brajtburg, J., S. Elberg, D. R. Schwartz, A. Vertut-Croquin, D. Schlessinger, G. S. Kobayashi, and G. Medoff. 1985. Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B. Antimicrob. Agents Chemother. 27:172-176.
13. Barjtburg, J., W. G. Powderly, G. S. Kobayashi, and G. Medoff. 1990. Amphotericin B: delivery systems. Antimicrob. Agents Chemother. 34:381-384.
14. Brajtburg, J., S. Elberg, G. S. Kobayashi, and J. Bolard. 1994. Amphotericin B incorporated into egg lecithin bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses. Antimicrob. Agents Chemother. 38:300-306.
15. Cook, J. A., and J. B. Mitchell. 1989. Viability measurements in mammalian cell systems. Anal. Biochem. 179:1-7.
16. Ernst, C., G. Dupont, H. Rinnert, and J. Lematur. 1978. Effet des variations de température sur le dichroisme circulaire, le spectre d'absorption et la diffusion Rayleigh de l'amphotéricine B en solution aqueuse et hydroalcoolique. C. R. Acad. Sci. Paris 286:175-177.
17. Ernst, C., J. Grange, H. Rinnert, G. Dupont, and J. Lematre. 1981. Structure of amphotericin B aggregates as revealed by UV and CD spectroscopies. Biopolymers 20:1575-1588.
18. Fisher, P. B., V. Bryson, and C. P. Schaffner. 1978. Polyene macrolide antibiotic cytotoxicity and membrane permeability alterations. J. Cell. Physiol. 97:345-352.
19. Gaboriau, F., M. Chéron, L. Leroy, and J. Bolard. 1997. Physicochemical properties of the heat induced-"super"aggregates of amphotericin B. Biophys. Chem. 66:1-12.
20. Guo, L. S. S., and P. K. Working. 1993. Complexes of amphotericin B and cholesteryl sulfate. J. Liposome Res. 3:473-493.
21. - selectivity of the permeability pathways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics. Eur. Biophys. J. 23:125-132.
22. Hemenger, R. P., T. Kaplan, and L. J. Gray. 1983. Structure of amphotericin B aggregates based on calculations of optical spectra. Biopolymers 22:911-918.
23. Jankneght, R., S. Marie, I. A. J. M. Baker-Wondenberg, and D. J. A. Crommelin. 1992. Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet. 23:279-291.
24. Janoff, A. S., W. R. Perkins, S. L. Saletan, and C. E. Swenson. 1993. Amphotericin B lipid complex (ABLC™): a molecular rationale for the attenuation of amphotericin B related toxicities. J Liposome Res. 3:451-473.
25. Jewell S. A., G. Bellomo, H. Thor, S. Orrenius, and T. Smith. 1982. Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium homeostasis. Science 217:1257-1262.
26. Lambing, H. E., B. D. Wolf, and S. C. Hartsel. 1993. Temperature effects on the aggregation state and activity of amphotericin B. Biochim. Biophys. Acta 1152:185-188.
27. Lamy-Freund, M. T., V. F. N. Ferreira, and S. Schreier. 1989. Polydispersity of aggregates formed by the polyene antibiotic amphotericin B and deoxycholate. A spin label study. Biochim. Biophys. Acta 981:207-212.
28. Lamy-Freund, M. T., S. Schreier, R. M. Peitzsch, and W. F. Wayne 1991. Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. J. Pharma. Sci. 80:262-260.
29. Lamy-Freund, M. T., V. F. N. Ferreira, A. Faljoni-Alario, and S. Schreier. 1993. Effect of aggregation upon the kinetics of autoxidation of the polyene antibiotic amphotericin B. J. Pharm. Sci. 82:162-166
30. Legrand, P., E. A. Romero, B. E. Cohen, and J. Bolard. 1992. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob. Agents Chemother. 36:2518-2522
31. Lopez-Berestein, G., G. P. Bodey, V. Fainstein, M. Keating, L. S Frankel, B. Zeluff, L. Gentry, and K. Mehta. 1989. Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 149:2533-2536.
32. Mazerski, J., J. Grzybowska, and E. Borowski. 1990. Influence of net charge on the aggregation and solubility behaviour of amphotericin B and its derivatives in aqueous media. Eur. Biophys. J. 18:1-6.
33. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
34. Sabra R., and R. A. Branch. 1992. Effect of amphotericin B on intracellular calcium levels in cultured glomerular mesanglial cells. Eur. J. Pharmacol. 226:79-85.
35. Szoka, F. C., Jr., and M. Tang. 1993. Amphotericin B formulated in liposomes and lipid based systems: a review. J. Liposome Res. 3:363-377.
36. Yamashita, K., V. Janout, V., E. M. Bernard, D. Armstrong, and S. L. Regen. 1995. Micelle/monomer control over the membrane-disrupting properties of an amphiphilic antibiotic. J. Am. Chem. Soc. 117:6249-6253.